ABSTRACT PURPOSE: To evaluate the monocular and binocular visual outcomes of LASIK with an aspheric micro-monovision protocol in emmetropic patients with presbyopia.
he treatment of presbyopia in emmetropic patients is currently one of the biggest challenges in refractive surgery and a number of different approaches have been used, including LASIK monovision, 1 corneal multifocal ablation, 2 corneal inlays, [3] [4] [5] [6] conductive keratoplasty, 1 intrastromal femtosecond concentric rings, 7, 8 and refractive clear lens exchange with multifocal or accommodative intraocular lenses (IOL). 9 We previously described the Laser Blended Vision (Carl Zeiss Meditec, Jena, Germany) technique in myopic 10 and hyperopic populations 11 that combines control of spherical aberration to increase depth of fi eld with micro-monovision (anisometropia of 1.50 diopters [D] in the nondominant eye irrespective of age). In emmetropic patients, as the refractive error correction is small, inducing signifi cant spherical aberration would require a multifocal ablation, but this has been shown to reduce quality of vision, such as decreased contrast sensitivity, 12 increased glare and halos, 12, 13 and loss of corrected distance visual acuity (CDVA). 14, 15 Emmetropic presbyopic patients often have high expectations because they already have good distance vision and are not used to wearing glasses. Therefore, refractive accuracy and safety (both in terms of quantity and quality of vision) are paramount in these patients. For this reason, the Laser Blended Vision module uses a low degree of asphericity in emmetropic patients and relies more on the near vision afforded by micro-monovision together with the depth of fi eld increase afforded by a change in spherical aberration.
PATIENTS AND METHODS
This study was a retrospective, noncomparative case series including 160 consecutive emmetropic presbyopic patients undergoing LASIK between November 15, 2007 and June 9, 2010 , at the London Vision Clinic, London, United Kingdom. Inclusion criteria were medically suitable for LASIK; no previous ocular, eyelid or orbital surgery; no visually signifi cant cataract; emmetropic refraction in both eyes; distancecorrected near visual acuity (DCNVA) of J3 or worse in both eyes; CDVA 20/20 or better in both eyes; and minimum 1-year follow-up. An emmetropic refraction was defi ned as spherical equivalent refraction уϪ0.88 D, manifest sphere рϩ1.00 D, and manifest cylinder р1.25 D. Informed consent and permission to use their data for analysis and publication were obtained from all patients.
Median follow-up after the primary treatment was 12.9 months. All patients who had not attended 1-year follow-up were contacted by telephone. Of these, 12 (7.5%) patients lived far from London or abroad and were unwilling to travel. These patients were classifi ed as lost to follow-up and were excluded from the analysis. Of the 148 patients included for analysis, the last time point after the primary procedure was 6 months for 1.7% of eyes (n=5) and 1 year for the remaining 98.3% of eyes (n=293). Eyes for which the last time point was earlier than 1-year follow-up underwent retreatment at that time.
The following represents the standard treatment protocol for emmetropic presbyopic patients in our practice since August 1, 2003.
PREOPERATIVE ASSESSMENT
A full ophthalmologic examination was performed by an in-house optometrist as described previously.
10,11

MICRO-MONOVISION ASSESSMENT
The protocol used to determine the amount of induced myopic target, or "add," to use in the nondominant eye has been described in detail previously. 10, 11 The age of the patient was not a consideration when choosing the add; rather an add of 1.50 D was used whenever possible and was reduced only if necessary until the patient reported no cross-blur (as defi ned previously 10, 11 ). The add was increased to Ͼ1.50 D only if the patient could not comfortably read J2. No contact lens monovision trials were performed. Patients were counseled to expect an adaptation period of at least 3 to 6 months and subjective cross-blur was recorded postoperatively using the following grading categories: none, slight, mild, moderate, and severe.
SURGICAL PROCEDURE
All patients underwent bilateral simultaneous LASIK using the MEL 80 excimer laser and VisuMax femtosecond laser by one of two surgeons (D.Z.R.
[63%], G.I.C [37%]). The CRS-Master software platform (Carl Zeiss Meditec) was used to generate the ablation profi les (version 2.1.6 until November 1, 2009, and version 2.3.0 after this date). Proprietary aspheric ablation profi les were used for all eyes, which incorporated a small amount of spherical aberration determined according to the patient's age, preoperative spherical aberration, and the amount of refractive correction; the profi les were intended to control the induction of spherical aberration to a level that would provide an increased depth of fi eld, but without affecting contrast sensitivity and quality of vision. Optical treatment zone diameters were 6.00 mm (in 17%), 6 .50 mm (in 49%), and 7.00 mm (in 34%). Intended fl ap thickness was 90 μm in 23%, 95 μm in 0.7%, 100 μm in 44%, 110 μm in 16%, and 120 μm in 17% of eyes. Flap diameter was 8.4 mm in 65%, 8.9 mm in 9%, and 9.2 mm in 26% of eyes.
POSTOPERATIVE EVALUATION
Patients were instructed to wear plastic shields while sleeping for 7 nights. Topical tobramycin 0.3%/dexamethasone 0.1% and ofl oxacin 0.3% were applied four times daily for the fi rst week, which is our standard protocol for broad spectrum prophylaxis. Patients were reviewed at 1 day and 1, 3, 6, and 12 months using our standard protocol as described previously. 10, 11 Slit-lamp examination was performed at all postoperative follow-up visits and superfi cial punctuate keratitis was recorded using a six-grade classifi cation system: none, trace, I-II (not visually signifi cant), and III-V (visually signifi cant). All postoperative examinations were conducted by one of seven in-house optometrists. Manifest refraction was performed based on a standardized protocol, 16 and all optometrists had undergone refraction training with this protocol.
A retreatment was offered to all patients who could gain two lines of uncorrected distance visual acuity (UDVA) and patients with cylinder Ͼ0.75 D. Retreatments were performed once stability was demonstrated over a 2-month interval (stability was defi ned as no change in sphere within Ϯ0.25 D and change in cylinder within Ϯ0.50 D).
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STATISTICAL ANALYSIS
Outcome measures were calculated according to the standardized graphs as originally defi ned by Waring.
17-19
The outcomes were analyzed for the primary treatment and for fi nal results after all treatments. For eyes that received retreatment, the refraction and vision at the time of retreatment were used for the primary outcome analysis. The mesopic contrast sensitivity was converted into log values before calculating statistics. The mean normalized mesopic contrast sensitivity ratio was calculated. 20 Student paired t tests were used to assess the change in mesopic contrast sensitivity, and to compare UDVA, CDVA, DCNVA, and uncorrected near visual acuity (UNVA) (logMAR). Average pre-and postoperative spherical aberration was calculated for a 6-mm analysis zone using Optical Society of America (OSA) notation. 21 Microsoft Excel 2007 (Microsoft Corp, Redmond, Washington) was used for data entry and statistical analysis.
RESULTS
Two hundred ninety-six eyes from 148 consecutive patients (41% male, 59% female) were included in the fi nal analysis. Median patient age was 55 years (range: 44 to 65 years). Table 1 shows descriptive statistics of the preoperative, intended, and attempted spherical equivalent refraction and the mean deviation from the intended spherical equivalent refraction after primary treatment and after all treatments grouped into distance and near eyes. Table 2 presents preoperative patient characteristics and target spherical equivalent refraction of the near eye. The right eye was dominant in 64% of patients. Figure 1 presents effi cacy in terms of UDVA and UNVA before and after the primary treatment and after all treatments grouped into binocular and distance and near eyes monocularly. Figure 2 presents the standard graphs for reporting refractive surgery, with the UDVA effi cacy histogram replaced by a histogram showing the change in lines of DCNVA (as the UDVA histogram is included in Figure 1 ). The attempted versus achieved scatterplot only includes data after all treatments. The stability plot includes data after the primary treatment only. The remaining four graphs include data after the primary treatment and after all treatments. Figure  3 presents the combined binocular distance and near visual acuity before and after all treatments. Figure 4 shows the defocus equivalent before and after all treatments for distance eyes only. Table A (available as supplemental material in the PDF version of this article) shows the mean UDVA, CDVA, and DCNVA before and after the primary treatment and after all treatments grouped into binocular LASIK for Presbyopia Correction/Reinstein et al and distance and near eyes. Binocular UDVA was one line better than monocular UDVA of the distance eye in 23 (16%) patients, these were the same in 116 (78%) patients, and binocular UDVA was one line worse than monocular UDVA of the distance eye in 9 (6%) patients. The improvement of binocular UDVA compared to monocular UDVA of the distance eyes was statistically signifi cant (P=.01). Table 3 shows the incidence of cross-blur 3 months after the primary treatment and 1 year after all treatments.
Of the eyes that lost one line of CDVA after all treatments, 18% were 20/12.5 preoperatively, 76% were 20/16 preoperatively, and 5% were 20/20 preoperatively; 99.3% (296/298) achieved CDVA 20/20 or better postoperatively. Table 4 shows the mean normalized mesopic contrast sensitivity ratio before and after the primary treatment at 3, 6, 12, and 18 cycles per degree (cpd). There was a statistically signifi cant improvement in mesopic contrast sensitivity at 3 cpd, and no statistically signifi cant change at 6, 12, and 18 cpd.
The following complications were experienced. Intraoperative epithelial defects occurred in 12 (4.1%) eyes, of which 5 eyes gained 1 line of CDVA and 7 eyes had no change in CDVA after the primary treatment. Table  B (available as supplemental data in the PDF version of this article) presents the percentage of eyes with superfi cial punctate keratitis before and 1 year after the primary treatment. One (0.3%) eye had visually significant superfi cial punctate keratitis at 1 year. Two (0.7%) cases of suction loss occurred during the creation of the fl ap interface. Both cases were managed using the standard repair mode to reapply the contact glass, resulting in normal fl aps with no bed irregularities as confi rmed intraoperatively.
In accordance with our retreatment policy and defi nition of stability, the retreatment rate was 11.8% (35/296 eyes), of which 14 (40%) were for distance eyes and 21 (60%) for near eyes. Of the 28 patients who underwent a retreatment, 7 (25%) received bilateral retreatments. The mean requested increase in myopic spherical equivalent refraction of the near eye was Ϫ0.27 D (range: Ϫ0.13 to Ϫ0.38 D). No patients required the myopic refraction of the near eye to be reduced from target. No patients requested the distance and near eyes be switched. Table 5 shows the mean spherical aberration before and after the primary treatment, and the change in spherical aberration grouped by distance and near eyes.
DISCUSSION
This aspheric micro-monovision protocol in a population of emmetropic presbyopic patients achieved results similar to those previously reported for myopic 10 and hyperopic populations. 11 Uncorrected binocular visual acuity of 20/20 at distance and J3 at near was achieved in 99% of patients with no loss of CDVA or contrast sensitivity.
The aspheric micro-monovision protocol was well tolerated, with only fi ve (3.4%) patients who did not tolerate anisometropia of Ϫ1.50 D and just one (0.7%) LASIK for Presbyopia Correction/Reinstein et al patient who did not tolerate Ϫ1.25 D on preoperative screening. Also, no patient requested the target spherical equivalent refraction of the near eye be reduced, nor did any patient request both eyes be corrected for distance vision after the primary treatment. The tolerance was similar to that observed in a hyperopic population 11 but better than that observed in a myopic population, where 12% of patients did not tolerate anisometropia of Ϫ1.00 D. 10 However, the myopic population was younger (median 49 years) than both the hyperopic (median 56 years) and emmetropic (median 55 years) populations. In the myopic population, all but one of the patients, who could only tolerate Ϫ0.75 D in the near eye, were younger than 49 years of age, whereas the majority of patients older than 54 years could tolerate Ϫ1.50 D in the near eye. This suggests that patients with mild presbyopia are less tolerant to a larger degree of anisometropia than patients with advanced presbyopia, which agrees with previous reports. 22 The tolerance to micro-monovision was also monitored by recording subjective cross-blur. Although mild/moderate cross-blur was observed in 35 (24%) patients at 3 months, only 10 (7%) patients reported mild/moderate cross-blur at 1 year, demonstrating that the neural adaptation process takes Ͻ3 months in most patients, but can take up to у1 year in a few patients.
Another interesting fi nding in this study was that the average DCNVA increased by 0.05 log units (approximately half a line) in both the distance and near eyes. This appears to demonstrate a small increase in depth of fi eld despite only a small degree of asphericity used in the ablation profi le. Alternatively, this could be a systematic effort-related bias.
Femtosecond LASIK monovision has been reported previously with the EC-5000 excimer laser (NIDEK Co Ltd, Gamagori, Japan) and IntraLase FS30 (Abbott Medical Optics, Santa Ana, California), although only the nondominant eye was treated using a target refraction of Ϫ1.50 D. 1 Mean UNVA was J3 compared with J1.5 in the present study. The study by Ayoubi et al 1 also reported results of monovision using conductive keratoplasty; spherical equivalent refraction regressed by 1.04 D (65%) over 18 months and induced average cylinder of 1.04 D, resulting in a mean UNVA of J5.5.
Multifocal ablation profi les have been described, but currently no published reports exist regarding their use in emmetropic presbyopes. However, published studies using multifocal ablation profi les in hyperopic and myopic patients show a reduction in quality of vision, including decreased contrast sensitivity, 12 increased glare and halos, 12, 13 and loss of CDVA. 14, 15 Pinhole intracorneal inlays are designed to increase the depth of fi eld based on the principle of pinhole optics to restore near and intermediate acuity without signifi cantly impacting distance vision, with the most common being the KAMRA (AcuFocus Inc, Irvine, California). The fi rst generation KAMRA inlay (ACI-7000, AcuFocus Inc) was 10-μm thick with 1600 microperforations. 4, 23, 24 The design and materials were then improved (ACI-7000PDT, AcuFocus Inc) to reduce the thickness to 5 μm and increase the number of microperforations to 8400. 5, 6 The results of the published studies using the KAMRA corneal inlay [4] [5] [6] 23, 24 are in- LASIK for Presbyopia Correction/Reinstein et al cluded in Table C (available as supplemental material in the PDF version of this article). The binocular UNVA was comparable to the present study, although the results with the new ACI-7000PDT were slightly worse (Waring 6 reported mean UNVA between J2 and J3, logMAR 0.14). The potential advantage of corneal inlays is that UDVA of at least 20/32 is retained in the eye treated for near vision, whereas only 16% of near eyes in the present study could achieve 20/32. However, binocular UDVA is similar with both techniques and the inlay population reported by Yilmaz et al 4, 23 showed that binocular UDVA decreased from 100% 20/20 to 73% 20/20 between 1 and 4 years. On the other hand, micro-monovision relies on the natural process of binocular neural summation and achieves excellent binocular vision despite comparatively blurred distance vision in the near eye. This may be partly explained by the fact that even the small refractive error has been corrected in the distance eye in the present study (as demonstrated by the defocus equivalent analysis in Figure 4 ), but needs to be confi rmed by further study. The safety of corneal inlays is not yet comparable to LASIK, with a 4% to 6% loss of two lines of CDVA reported in two studies 5, 24 and a significant decrease in contrast sensitivity in the two studies that reported contrast sensitivity data. 6, 24 Refractive intracorneal inlays are also being used to treat presbyopic patients. The fi rst refractive corneal inlays (Permavision; Anamed Inc, Anaheim, California) were associated with poor refractive predictability and loss of CDVA. 25 More recent models have improved the design, such as the Flexivue Microlens (Presbia, Los Angeles, California), 26 the PresbyLens (ReVision Optics Inc, Lake Forest, California), and the Invue Lens (Biovision AG, Bruggs, Switzerland). Using the Invue Lens in a population of emmetropic patients with presbyopia, binocular UDVA was 20/20 or better in 20% of patients and 20/25 or better in all patients, and binocular UNVA was J2 or better in 76% and J3 or better in 98% of patients. 27 No eyes lost more than one line of CDVA; however, there was a decrease in contrast sensitivity.
Refractive lens exchange has also been used as a treatment for emmetropic presbyopes by combining clear lens extraction with multifocal or accommodating IOLs to address myopic and hyperopic refractive errors, including presbyopia, and simultaneously eliminating the need for cataract surgery in the future. 9 The outcomes reported in the study of 46 eyes by Alfonso et al 9 were good with mean UDVA of 20/21, mean UNVA of J1.5, and no loss of 2 lines of CDVA. However, refractive lens exchange removes all residual accommodation and intraocular surgery introduces the risk of potentially catastrophic complications, such as the 0.07% risk of endophthalmitis, 1% to 6% risk of macular edema, 0.04% risk of suprachoroidal hemorrhage, 0.25% to 0.41% risk of retinal detachment, and 7% to 31% risk of posterior capsular opacifi cation. 28 This seems a large risk to introduce for 50-to 60-year-old patients with good distance vision when less than half are likely to undergo cataract surgery during their lifetime. 29 Recently, a new technique has been suggested in which a series of concentric cylindrical ring cuts are created intrastromally using a femtosecond laser to induce a central steepening to improve near vision (INTRACOR; Technolas Perfect Vision GmbH, Munich, Germany). 7, 8 The study by Ruiz et al 7 reported mean UNVA of J1.5 at 6 months; however, 2 (2.4%) eyes lost 2 lines CDVA. A prospective study by Holzer et al 8 reported mean logMAR UNVA of 0.26 (between J2 and J3) and a loss of one line of CDVA in 42% and two lines of CDVA in 8.3% of eyes. At this stage, UNVA and safety do not compare with the other treatment modalities, the long-term stability of the central induced steepening is unknown, contrast sensitivity and quality of vision have been reported to be reduced, 30 refractive error cannot be corrected simultaneously, and a retreatment is not currently possible.
This aspheric micro-monovision protocol achieved functional binocular uncorrected distance and near vision without compromising safety in terms of CDVA or contrast sensitivity, while enabling simultaneous correction of even small refractive errors; a combination that has not been demonstrated with any other presbyopic treatment option. 
